BMC Cancer

official impact factor 3.15

Open Access Highly Access Research article

Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study

Ivette F Emery*, Chiara Battelli, Paul L Auclair, Kathleen Carrier and Daniel M Hayes

BMC Cancer 2009, 9:333 doi:10.1186/1471-2407-9-333

No comments have yet been made on this article.

Post a comment